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Objectives: The perioperative mortality for people with ruptured abdominal aortic aneurysms (RAAA) has not changed
for two decades. Of patients who survive long enough to undergo open repair for ruptured aneurysms, half die (48%; 95%
confidence interval [CI] 46 to 50). Randomized trials have shown that endovascular aneurysm repair (EVAR) for nonruptured
abdominal aortic aneurysms decreases perioperative mortality compared with open repair. EVAR may similarly benefit patients
with RAAA. We aimed to summarize studies of patients undergoing EVAR for ruptured aneurysms.
Methods: Two reviewers searched Medline and EMBASE databases from 1994 to July 2006, Cochrane Database of Systematic
Reviews, the Database of Abstracts of Reviews of Effectiveness, the Cochrane Central Register of Controlled Trials, Best
Evidence 1994 to 2006, reference lists, clinical trial registries, and conference proceedings; we also contacted authors. All
published and unpublished studies in which a group of people with ruptured aneurysms, assessed objectively by imaging, was
treated with EVAR (REVAR) were eligible. We used the generic inverse variance function of the REVMAN software to pool
results for death in hospital. Sensitivity analyses, using prespecified subgroups, explored heterogeneity between studies.
Results: Pooled mortality in 18 observational studies describing 436 people who underwent REVAR was 21% (95% CI 13 to
29); however, 90% of the heterogeneity between studies was not explained by chance alone. Surgical volume explained
substantial heterogeneity. According to study-specific criteria, 47% (95% CI 39 to 55) of people with ruptured aneurysms were
potentially eligible for REVAR.
Conclusions: Mortality in people who underwent REVAR is lower than that in historical reports of unselected people
undergoing open repair. Further investigation is needed to determine whether the difference in mortality is attributable to
patient selection alone or to this new approach to treatment. (J Vasc Surg 2008;47:214-21.)Abdominal aortic aneurysms occur in 1% (95% confi-
dence Interval [CI] 1 to 2) of women and 6% (95% CI 5 to
6) of men over the age of 64 years.1 In a population study
in Malmo, Sweden, the incidence of ruptured aneurysms
increased from 5.6 per 100,000 person-years in 1971 to
1986 (95% CI 4.9 to 6.3) to 10.6 per 100,000 patient-
years in 2000 to 2004 (95% CI 8.9 to 12.4).2 Mortality of
people with ruptured aneurysms is 85% (95% CI 80 to 91),
of which 66% (95% CI 58 to 73) die before reaching
hospital or without operation.3 Perioperative mortality in
people who underwent open repair was 48% (95% CI 46 to
50) in a meta-analysis of 171 observational studies,4 and
41% (95%CI 40 to 42) in a recent population-based study.5
The mortality of open repair of ruptured aneurysms has not
improved significantly in the last two decades.6
Endovascular aneurysm repair (EVAR) is the luminal
exclusion of an aneurysm from circulatory flow using a con-
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214duit (endograft) inserted from a remote access vessel and
deployed under fluoroscopic guidance. Two randomized tri-
als in people with asymptomatic aneurysms reported a re-
duced risk of perioperative death with EVAR compared with
open repair (pooled relative risk [RR] 0.34, 95% CI 0.17 to
0.67,P 0.002).7,8 Given the high perioperativemortality of
open repair for people with ruptured aneurysms and the less
invasive nature of EVAR compared with open repair, we
conducted this systematic review to address the hypothesis
that endovascular repair of ruptured aneurysms (REVAR)
might be associated with lower mortality than open repair.
EVAR of ruptured aneurysms (REVAR) was first per-
formed in April 19949 and first published by another group
later that year.10 To our knowledge, a single randomized
controlled trial of 32people has been conducted.11The rest of
the evidence is observational. Themost recent previous review
was published 4 years ago, was not conducted systematically,
did not describe study quality, and did not provide a meta-
analysis of outcome data.12We conducted a systematic review
to answer the question: in people with ruptured aneurysms
undergoing endovascular aneurysm repair, what is the in-
hospital mortality and morbidity?
METHODS
We used guidelines from the meta-analysis of observa-
tional studies conference.13 Our checklist is available online
(Table I, online only).
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databases from 1994 (the first reported) to June 2006
using OVID software and the search strategies described in
the Appendix. We used synonyms for endovascular, en-
doluminal, and endograft because MeSH indexing words
for endovascular repair have not been established. We
searched the CochraneDatabase of Systematic Reviews, the
Database of Abstracts of Reviews of Effectiveness, the
Cochrane Central Register of Controlled Trials, Best Evi-
dence 1994 to 2006, and two clinical trials registry web
sites (www.clinicaltrials.gov and www.clinicaltrials.com)
using the terms ruptured aneurysm and endovascular re-
pair. We also reviewed reference lists of review articles,
conference proceedings, and the files of one of the investi-
gators (CSC).
Eligibility criteria. We established eligibility criteria
before searching. Eligible studies described mortality in
groups or subgroups of patients with ruptured infrarenal
abdominal aortic aneurysms in whom endovascular repair
was attempted. Studies including people with other condi-
tions (ruptured thoracic or thoracoabdominal aneurysms,
symptomatic but unruptured aneurysms) were included
only if mortality data on people with ruptured infrarenal
abdominal aortic aneurysms were reported separately.
Studies that did not define ruptured aneurysm based on
computerised tomography (CT) or ultrasound and studies
of aneurysm rupture after placement of an endovascular
graft were excluded. Where reports of the same patient
group were published in duplicate, the report with the
greatest number of patients was included.
Two reviewers assessed all identified citations using
Reference Manager (Version 10, ISI ResearchSoft). When
an English-language abstract was available, we used this to
determine whether to obtain full text, and obtained full text
on all other potentially-relevant citations. We did not ex-
clude studies published in languages other than English.
After the retrieval of full text articles, we recognized a large
number of publications describing few patients, and we
decided to exclude studies of fewer than 10 people under-
going REVAR to minimize selection bias. We also identi-
fied four analyses of outcomes from Medicare databases
that contained little clinical detail and decided to exclude
these if they included patients also reported (in more detail)
in individual studies.
Data quality. We drew on published systematic re-
views and guidelines for the quality assessment of nonran-
domized trials13-17 in selecting items for quality assessment
and used these to develop a standardized method for
classification.15,16 In REVAR studies, we anticipated that
control groups might include patients who were unsuitable
for the procedure and, therefore, would differ systemati-
cally from groups undergoing REVAR. We, therefore,
planned to summarize results in patients undergoing
REVAR, rather than to summarize relative risks comparing
patients undergoing REVAR with controls. Each study’s
description of controls was included as an element of qual-
ity assessment. Other quality issues were direction of in-
quiry,18 blinding of outcome assessors, prespecification ofoutcomes, the use of an algorithm for assessing eligibility
for REVAR, and the disclosure of the source of funding.15
These quality issues have specific importance in this review:
a well-defined control group would improve generalizabil-
ity by providing a description of the population of patients
presenting with RAAA, prospective data collection may be
more complete than that done retrospectively, blinded
outcome assessors would be less likely to bias results, pre-
specified outcomes provide a systematic framework for
prospective outcome assessment, the use of a clinical algo-
rithm is a surrogate indicator of a well-organized team and
the source of funding has been shown to influence re-
sults.15
Data extraction. Data were collected independently
by two reviewers with content and methodologic expertise
(TMM, LGO) using an electronic extraction form. On two
occasions, 2 weeks apart, we contacted authors of unpub-
lished reports, conference proceedings, and papers with
incomplete data to request information that was missing
from published work.
Selection of outcomes and meta-analysis. We chose
in-hospital mortality as the primary outcome. We also
extracted data on associated morbidities, including renal
morbidity, defined as patients requiring dialysis (both tem-
porary and permanent) and patients who developed eleva-
tions in creatinine but did not require dialysis, paraplegia,
and abdominal compartment syndrome. We recorded the
proportion of all patients who presented with ruptured
aneurysms who were treated with REVAR and assessed
reasons for ineligibility, if provided by the authors. Mortal-
ity at long term follow-up was recorded where available.
Potential sources of heterogeneity and sensitivity
analyses. We performed three prespecified sensitivity anal-
ysis in the hope of explaining some of the anticipated
heterogeneity:19 the direction of inquiry, the use of a
systematic algorithm to determine eligibility for EVAR, and
the expertise of surgeons and their endovascular teams
(based on the volume of REVAR procedures described in
each report). A cut point of 30 procedures was used to
define expertise based on a recent cumulative sum
(CUSUM) analysis showing that complication rates stabi-
lize after 31 procedures.20
Statistics. We expressed agreement for eligibility and
quality decisions using Cohen’s Kappa (SPSS, Version
12.0, Chicago, Ill). Outcome data were pooled using the
generic inverse variance function of Review Manager (Re-
view Manager, Version 4.2, Cochrane Collaboration). We
used the I2 statistic to quantify heterogeneity and, in antic-
ipation of high heterogeneity associated with observational
studies,19 we did not prespecify a level of I2 that would
justify pooling results.
RESULTS
Search. After deduplication, we identified 3070 cita-
tions. Medline and EMBASE citations overlapped by 24%.
Kappa for eligibility decisions was 0.71. We retrieved full-
text for 114 citations, which yielded 18 independent cohort
studies with more than 10 participants (17 papers and one
JOURNAL OF VASCULAR SURGERY
January 2008216 Mastracci et alabstract: Fig 1). All the potentially-relevant studies were
written in English.
Study characteristics. Table II shows the characteris-
tics of included studies. Tabulation of excluded studies is
shown in Table III, online only. Table IV summarizes
clinical variables.
Study methodology and quality assessment. Table
V, online only, summarizes the quality of the included
studies. A control group was not described in seven stud-
ies,21-27 was a historic cohort of patients undergoing open
Fig 1. Flowchart of systematic review: search strategy and ratio-
nale for exclusion of reports. RCT, Randomized controlled trial;
REVAR, ruptured endovascular aneurysm repair;RAAA ruptured
abdominal aortic aneurysm, RTAA, ruptured thoracic aneurysm
repair; SAAA, symptomatic abdominal aortic aneurysm.repair in three studies,28-30 was a group of patients withsymptomatic AAA in one study,31 was a concurrent cohort
of patients who were ineligible for REVAR (anatomically
unsuitable or hemodynamically unstable) in two stud-
ies,32,33 was a concurrent cohort of patients who were
either ineligible for REVAR or who, though eligible, un-
derwent open repair because equipment or staff were lack-
ing at the time of their presentation in two studies,34,35 was
a concurrent cohort whose selection was not described in
two studies,36,37 and a combination of patients undergoing
REVAR prior to implementation of an algorithm and a
historical and concurrent group of patients undergoing
open repair in one.38 No study included in this review
reported a control group comprised entirely of concurrent
patients who were eligible for REVAR who underwent
open repair.
The direction of inquiry was retrospective in
eight studies,21,28-30,34,36,37 prospective in nine stud-
ies22,25-27,31-33,35,38 and not reported in one study.24
None of the included studies reported blinding of the
outcome assessors. Outcomes were prespecified in nine
studies (50%).23,29,30,32-36,38 An algorithm to assess pa-
tients’ eligibility for REVAR was used in 14 studies
(72%).21-24,26,28-33,35,37,38 Funding sources were re-
ported in two studies (11%).25,33 Funding was unde-
clared in 16 studies, 10 of which declared “no conflict of
interest”.22-24,27,29-31,38-40
Primary results and sensitivity analyses. In the 18
observational studies included in this review, in-hospital
mortality for patients who underwent REVAR varied from
0% (95% CI 0 to 28)30 to 45% (95% CI 23 to 67)25(Fig 2).
Pooled mortality was 21% (95% CI 13 to 29), though
heterogeneity (I2) was high, 90.2%.
Heterogeneity was explored in three sensitivity analy-
ses. In-hospital mortality for prospective studies was 23%
(95% CI 15 to 31) compared with retrospectively reported
studies, which was 19% (95% CI 7 to 30). The I2 value for
the prospective studies decreased to 64.5% (Fig 3).
In the 14 studies that included details of the algorithm
used, the pooled in-hospital mortality was 18% (95% CI 10
to 26; I2 86.9%). For studies that did not report using an
algorithm, it was 32% (95% CI 20 to 44; I2 90.2%) (Fig 4).
In a subgroup analysis by surgical volume (as a surro-
gate for expertise; assessed as 30 cases reported), the
in-hospital mortality for groups that reported more than 30
REVAR is 19% (95% CI 10 to 28; I2 57.1%) and for those
that reported 30 or fewer procedures, 22% (95% CI 12 to
33; I2 90.3 %) (Fig 5).
Details of algorithms for selection of patients for
REVAR. A summary of selection criteria for REVAR and
reasons for patients’ ineligibility for REVAR is found in
Table VI, online only. In six studies, the presence of an
endovascular specialist was required.25,29,31-33,38 CT scans
were required if the patient was hemodynamically stable in
all but two studies.25,26 A threshold systolic blood pressure
or hemodynamic parameters that mandated abandoning
REVAR in favor of emergency laparotomy were explicitly
stated in two studies.33,38 Using a random effects model,
53% (95% CI 45 to 61; I2 54%) of patients were ineligible
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patients deemed ineligible because resources for REVAR
were not available at the time of their presentation (12% of
people in studies reporting this issue).
Details of management protocols. Permissive hypo-
tension, also described as hypotensive hemostasis by some
authors, a resuscitation technique in which the administra-
tion of intravenous fluids and blood is limited to maintain a
lower systolic blood pressure, usually according to a proto-
col, was used in 13 studies.21-27,29,31,33,35,37,38 No authors
recommended the routine use of an aortic occlusion bal-
loon. Critical aortic dimensions were specified as aspects of
anatomic eligibility criteria in nine studies.22,24,25,29-33,35
Adverse events and long-term follow-up. Table
VIII, online only, describes major adverse events. Most
authors did not report standardized definitions to classify
outcomes: one author reported a definition for renal failure
Table II. Table of studies included in the systematic revie
Reference Location
Years
described
Scharrer-Pamler 200321 Ulm, Germany 1995–2001
Resch 200328 Malmo, Sweden 2001–2002
Castelli 200537 Varese, Italy 2001–2004
Lee 200429 Gainesville, Florida, USA 1997–2004
Hechelhammer 200522 Zurich, Switzerland 1997–2003
Peppelenbosch 200523 The Netherlands & Gent,
Belgium
1997–2004
Gerassimidis 200524 Thessaloniki, Greece 1998–2004
Kapma 200532 Groningen, The
Netherlands
1998–2004
Mehta 200631 Albany, New York, USA 2002–2006
Leon 200536 Maywood, Illinois, USA 1995–2003
Brandt 200530 Kiel, Germany 2001–2004
Larzon 200534 Orebro, Sweden 2001–2004
Alsac 200535 Creteil, France 2001–2004
Hinchliffe 200125 Nottingham, UK 1994–2000
Veith 200326 New York, USA 1994–2003
Moore 200638 Calgary, Canada 2001–2006
Lagana 200627 Varese, Italy 2001–2004
Peppelenbosch 200633 International
collaboration
2003–2004
REVAR, Endovascular repair of ruptured aortic aneurysm.not requiring dialysis,27 and one author used a publishedclassification system for paraplegia.23 Some authors re-
ported mortality for various durations of long-term fol-
low-up (Table IX, online only). Because of the low number
of events and the lack of standard definitions, we decided
not to pool results for adverse events or long-term
mortality.
DISCUSSION
The pooled estimate of mortality for REVAR, based on
observational studies included in this systematic review, is
21% (95% CI 13 to 29), but substantial heterogeneity
between studies exists (I2 90.2%), and reliance should not
be placed on the point estimate. Differences in study quality
alone cannot account for the heterogeneity, but restricting
the analysis to studies of teams with greater surgical expe-
rience did lead to substantial reduction in heterogeneity (I2
57.1%), though not to the point conventionally considered
d meta-analysis of ruptured endovascular aneurysm repair
search design
Number of
ruptured
aneurysms
reported Graft morphology
Number of
REVAR
attempted
se series 67 19 bifurcated, 4 aorto-iliac 24
trospective
ohort
Not
reported
6 bifurcated, 10 aorto-
iliac, and 2 custom
made
21
oss-sectional 46 21 bifurcated and 4
aortomonoiliac
25
trospective
ohort
36 13 bifurcated 13
se series 89 35 bifurcated and 2 aorto-
iliac
37
se series 101 3 bifurcated and 32
aortomonoiliac
35
se series 40 14 bifurcated grafts, 10
mono-iliac, and 2
custom made
23
oss-sectional 262 Majority of bifurcated
grafts were used, but
the exact numbers were
not extractable
25
se series 85 34 bifurcated and 6
mono-iliac
42
trospective
ohort study
2118 Not described 55
trospective
ohort study
24 3 bifurcated and 8 mono-
iliac
11
oss-sectional 50 15 bifurcated 15
oss-sectional 37 8 bifurcated and 8 mono-
iliac implanted
17
se series 20 20 aortomonoiliac 20
se series Not
reported
Montefiore Endograft
System
30
oss-sectional 115 Aortouniiliac or
aortobiiliac devices
19
se series Not
reported
Not described 23
ntrolled trial 100 Not described 49w an
Re
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Re
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Cr
Re
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Ca
Ca
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Cr
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Ca
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Coacceptable for accepting a pooled analysis ( 50%).
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represents, to our knowledge, the first systematic attempt
to summarize results of observational studies of endovas-
cular repair of ruptured aneurysms. We conducted a sensi-
tive search using multiple databases and extracted data in
duplicate. We assessed quality in the studies according to
six items on which we reached consensus before data ex-
traction. We hypothesized that control groups would be
variable in their composition and that many would be
clearly biased: the data confirmed our concerns and justified
our decision to summarize only the REVAR arms of the
controlled comparisons reported. However, the method-
ologic quality of the studies included was low (Table IV),
and heterogeneity was substantial.
Relationship of this work to other studies. We ob-
served less heterogeneity between results when divided
according to surgical volume, though the point estimates
for mortality did not differ between groups with larger or
smaller volumes. This observation adds to other data that
support the importance of experience in REVAR.38 Fur-
ther information on mortality in REVAR is available from
Medicare databases, which are excluded from the formal
meta-analysis because they included patients from the indi-
vidual clinical studies. For the United States as a whole, for
a 5% sample of US inpatients, for patients from Illinois, and
for patients from New York, California, Florida, and New
Jersey combined, mortality with REVAR has been reported
to be 53%, 33%, 36%, and 39%, respectively.36,41-43 These
rates are higher than those in our summary. We excluded
case series of 10 of fewer patients, since we felt these results
would likely be biased in that investigators were more likely
to report, and journals to publish, small series if their results
were good. However, in excluding these studies, we have
Table IV. Summary of clinical information from
included studies
Characteristic
Outcome number, or
mean and SD
Number of
studies
reporting
Number of studies 18
Total number of ruptured
aneurysms reported
3213 16
Total number of REVAR
reported
436 18
Study duration 3.8 y (SD 2.8) 18
Participant age 73.8 y (SD 2.6) 18
Time in CT scanner 27.7 min (SD 14.1) 3
Time from ER to OR 71.8 min (SD 27.9) 7
Estimated blood loss 483 mL (SD 386) 7
Total number of units of
PRBC transfused
(intraoperative)
3.6 units (SD 1.8) 9
Total fluoroscopy time 18.9 min (SD 0.14) 2
REVAR, Endovascular repair of ruptured aortic aneurysm; SD standard
deviation; CT computed tomography; ER emergency room; OR operating
room; PRBC, packed red blood cells.
Data in this table are simple unweighted means of data reported in the
individual studies.limited our analysis to the work of groups with largervolumes and, therefore, possibly better outcomes because
of greater experience. It is not possible to determine from
the data at hand whether the difference between registry
rates and our summary of the larger individual studies
represents chance, publication bias, or the effect of greater
expertise in centers with larger volumes.
We hypothesized a priori that studies reporting the use
of algorithms to assess patients for eligibility for REVAR
might show better outcomes than those without algo-
rithms, either because appropriate patient selection is essen-
tial to technical success, or because the use of an algorithm
is a surrogate for an organized approach to the problem,
and a marker of quality of overall care. Mortality was 18%
(95% CI 10 to 26; I2 86.9%) in studies reporting an
algorithm and 32% (95% CI 20 to 44; I2 90.2%) in those
without. Confidence intervals overlap, but the difference in
the point estimates are consistent with a single center report
of mortality of 29% (95% CI 19 to 40) before the imple-
mentation of an algorithm and 13% (95% CI 2 to 23)
afterwards.38 Common elements of algorithms were a strat-
egy for permissive hypotension, CT scanning before inter-
vention if the patient’s condition permitted, anatomic eli-
gibility criteria similar to those used in the assessment for
elective repair, a hemodynamic threshold for conversion to
open repair, and the involvement of a trained team.
By design, an algorithm selects the most stable patients
to undergo REVAR. In our review, 47% of patients were
eligible, and some of the ineligible patients were so classi-
fied for administrative rather than clinical reasons (12% of
those in studies reporting this data; Table VII, online only).
We did not perform statistical comparisons of patients
treated with REVAR with those in the control groups
reported as we felt the composition of the control groups
was too biased to permit meaningful comparison. Histori-
cally, the mortality rate for patients with ruptured aneu-
rysms who undergo open surgery is 41% to 49%.4,5 Centers
that report outcomes for all RAAAs after the introduction
of REVAR have published mortality rates of 24% to
46%.34,35,44A randomized trial (published after our cut-off
date for inclusion of studies) screened 103 patients and
randomized 32 to immediate open surgery or to consider-
ation for REVAR. Mortality was 53% (95% CI 29 to 77) in
the group assigned to open and 53% (95% CI 28 to 79) in
the REVAR group, but the sample size was too small to
draw statistically significant conclusions.11 It is not possible
to conclude from our own work or from these related
studies whether the low pooledmortality we observed (21%
[95% CI 13 to 29]) is due to chance, due to selection of
patients for REVAR, or due to benefit from the technique
in improving outcomes.
Implications of the study for clinical practice.
Though it is not possible to conclude that the results in
patients treated with REVAR are better than those for open
surgery, this work offers support for this technique in
patients in centers where adequate expertise and resources
are available without incurring delay. We hope that our
summary of accumulated experience with REVAR will be
useful to those who are planning or running endovascular
JOURNAL OF VASCULAR SURGERY
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providing insight into different practices. A summary of
algorithms used in different centers is available online (Ta-
ble VII, online only).
Unanswered questions and implications for
research. We believe that the evidence summarized here is
Fig 2. Forest plot of observational studies of endovasc
effects model.
Fig 6. Proportion of patients ineligible for endovascula
this variable, pooled using a random effects model.inadequate to recommend widespread adoption of strate-gies that include REVAR, and that a large multicenter
randomized trial comparing such a strategy with open
repair is needed. In the interim, we recommend continued
reporting of observational results. Ideally, centers in which
REVAR is employed should contribute data to a central
registry. We have identified opportunities for improvement
epair of ruptured aneurysms summarized by a random
air of ruptured aneurysms: forest plot of trials reportingular rr repin the quality of reporting of nonrandomized studies of this
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controls has been particularly problematic. We suggest that
a suitable control group comprises those patients who were
eligible for REVAR according to center-specific protocols
but who did not undergo the procedure because of admin-
istrative reasons or resource constraints. Describing results
for subgroups of patients categorized according to hemo-
dynamic stability, in both REVAR and control groups, will
begin to address the issue of which patients might benefit
most from REVAR. It is possible that subgroups of pa-
tients, perhaps those who are very unstable hemodynami-
cally, or whose previous intra-abdominal pathology
strongly contraindicates open repair, will benefit most from
this technique: data on these issues should be included in
any registry and in future publications. We also recommend
reporting of overall event rates for consecutive patients
presenting with RAAA, regardless of treatment method.
Finally, long-term outcomes over years to decades, ad-
dressed in only a few of the studies summarized here,
should be included in future reports as they become avail-
able.
CONCLUSIONS
Short-term mortality after endovascular repair of rup-
tured aneurysms appears promising in the selected patients
who have undergone the procedure. Further research is
needed to refine the indications for REVAR in patients
presenting with RAAA.
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Search Strategy used for EMBASE Search
1 exp Aorta Aneurysm/
2 aneurysm$.mp.
3 aort$.mp.
4 2 and 3
5 1 or 4
6 exp blood vessel rupture/
7 aneurysm$.mp.
8 ruptur$.mp.
9 acute.mp.
10 urgen$.mp.
11 emergen$.mp.
12 8 or 9 or 10 or 11
13 7 and 12
14 6 or 13
15 exp blood vessel transplantation/
16 exp blood vessel prosthesis/
17 exp blood vessel shunt/
18 exp endovascular surgery/
19 endovascular.mp.
20 endograf$.mp.
21 endoprosthes$.mp.
22 endolum$.mp.
23 endostent$.mp.
24 19 or 20 or 21 or 22 or 23
25 15 or 16 or 17 or 18
26 24 or 25
27 5 and 14 and 26
28 Animal/
29 Human/
30 28 not 29
31 27 not 30
32 limit 31 to yr”1994 - 2006”OVID (Medline) Search Strategy
1 exp aortic aneurysm/
2 aneurysm$.mp.
3 aort$.mp.
4 2 and 3
5 1 or 4
6 exp aneurysm, ruptured/
7 aneurysm$.mp.
8 ruptur$.mp.
9 acute.mp.
10 urgen$.mp.
11 emergen$.mp.
12 8 or 9 or 10 or 11
13 7 and 12
14 6 or 13
15 exp blood vessel prosthesis implantation/
16 exp blood vessel prosthesis/
17 exp stents/
18 endovascular.mp.
19 endograf$.mp.
20 endoprosthes$.mp.
21 endolum$.mp.
22 endostent$.mp.
23 18 or 19 or 20 or 21 or 22
24 15 or 16 or 17
25 23 or 24
26 5 and 14 and 25
27 animals.sh.
28 humans.sh.
29 27 not 28
30 26 not 29
31 limit 30 to yr”1994 - 2006”
d using a random effects model.
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January 2008221.e2 Mastracci et alFig 3. Online only. Sensitivity analysis by direction of
studies of ruptured endovascular aneurysm repair, pooleinquiry, for in hospital mortality: forest plot of observational
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Volume 47, Number 1 Mastracci et al 221.e3Fig 4. Online only. Sensitivity analysis by presence of an algorithm for endovascular repair of ruptured aneurysms, for
in hospital mortality: forest plot of observational studies, pooled using a random effects model.
JOURNAL OF VASCULAR SURGERY
January 2008221.e4 Mastracci et alFig 5. Online only. Sensitivity analysis by volume of procedures reported (30 REVAR vs30 REVAR): forest plot
of observational studies of ruptured endovascular aneurysm repair, pooled using a random effects model.
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Volume 47, Number 1 Mastracci et al 221.e5Table I, online only. Checklist according to the guidelines of the meta-analysis of observational studies conference
(MOOSE)
Criteria Page, figure, or table number
Background
Problem definition Page 3
Hypothesis statement Page 3
Description of outcome(s) Page 3
Type of exposures or intervention used Page 3
Type of study designs used Page 3
Study population Page 3
Search strategy
Qualifications of searchers Page 5
Search strategy (including time period and keywords) Appendix
Effort to include all available studies, contact with authors Page 5
Databases and registries searched Page 4
Search software used Page 4
Use of hand searching Page 4
List of citations located and those excluded, including justification
Method of addressing articles published in languages other than
English
Page 4
Method of handling abstracts and unpublished studies Page 4
Description of contact with authors Page 5
Methods
Description of relevance or appropriateness of studies assessing the
hypothesis to be tested
Page 4
Rationale for the selection and coding of data Page 4 to 5
Documentation of how data were classified and coded Page 5
Assessment of confounding Page 4 to 5
Assessment of study quality, including blinding of quality assessors . . . Page 4 to 5
Assessment of heterogeneity Page 5
Description of statistical methods Page 6
Provision of appropriate tables or graphics Table I to VIII, Figs 1 to 5
Results
Graphic summarizing individual study estimates and overall estimate Fig 2
Table giving descriptive information for each study included Table II
Results of sensitivity testing Page 7, Figs 3 to 5
Indication of statistical uncertainty of findings Confidence intervals, page 7
Discussion
Quantitative assessment of bias Not possible with this design
Justification for exclusion Page 9
Assessment of quality of included studies Page 9 to 10
Conclusions
Consideration of alterative explanations for observed results Page 10
Generalization of the conclusions Page 11
Guidelines for future research Page 10 to 11
Disclosure of funding source Page 11
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January 2008221.e6 Mastracci et alTable III, online only. Studies excluded from the systematic review and meta-analysis of ruptured endovascular
aneurysm repair
Reference Location
Years
described Reason for exclusion
Yilmaz 200245 Eindhoven, The Netherlands 1999–2001 Outcomes for symptomatic and ruptured aneurysms
considered in combined analysis.
Orend 200246 Ulm, Germany 1995–2000 Outcomes for thoracic and infrarenal considered in
combined analysis.
Orend 200347 Ulm, Germany 1995–2003 Outcomes for thoracic and infrarenal considered in
combined analysis.
Moore 200548 Calgary, Canada 1999–2005 These patients are included in a more recent
publication
Verhoeven 200249 Groningen, The Netherlands 1998–2001 These patients are included in a more recent
publication
Verhoeven 200450 Groningen, The Netherlands 1996–2003 These patients are included in a more recent
publication
Veith 200351 New York, USA 1994–2003 These patients are included in a more recent
publication
Ohki 200152 New York, USA 1994–2001 These patients are included in a more recent
publication
Ohki 199953 New York, USA 1994–1998 These patients are included in a more recent
publication
Veith 200254 New York, USA 1994–2002 These patients are included in a more recent
publication
Ohki 200055 New York, USA 1994–2000 These patients are included in a more recent
publication
Metha 200556 Albany, New York, USA 2002–2004 These patients are included in a more recent
publication
McKinsey 200643 USA 1999–2003 Some of these patients are included in other
publications
Greco 200642 New York , California, New Jersey,
and Florida, USA
2000–2003 Some of these patients are included in other
publications
Dillavou 200641 USA 2000–2003 Some of these patients are included in other
publications
Franks 200643 Leicester, UK 1996–2003 Outcomes for ruptured and symptomatic
considered in combined analysis
Lachat 200257 Zurich, Switzerland 1998–2001 These patients are included in a more recent
publication
Peppelenbosch 200358 The Netherlands & Gent, Belgium 2001–2002 These patients are included in a more recent
publication
Pfammatter 200459 Zurich, Switzerland 1998–2004 These patients are included in a more recent
publication
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Volume 47, Number 1 Mastracci et al 221.e7Table V, online only. Methodologic quality of studies included in the systematic review and meta-analysis of ruptured
endovascular aneurysm repair
Reference
Direction of
inquiry Control group
Outcome
assessors
blinded
Outcomes
specified
a priori
Algorithm
used Funding
Scharrer-Pamler21 Retrospective No control group Cannot
tell
No Yes Not declared
Resch28 Retrospective Historical cohort of patients with
ruptured aneurysms treated
with open repair at the same
center before the introduction
of REVAR
No No Yes Not declared
Castelli37 Retrospective Concurrent cohort of patients
with ruptured aneurysms
treated with open repair but
their selection was not well
described
No No Yes Not declared
Lee29 Retrospective Historical cohort of patients with
ruptured aneurysms treated
with open repair at the same
center before the introduction
of REVAR
No Yes Yes Competition of interest: none
Hechelhammer22 Prospective No control group Cannot
tell
Cannot
tell
Yes Competition of interest: none
Peppelenbosch23 Retrospective No control group No Yes Yes Competition of interest: none
Gerassimidis24 Cannot tell No control group Cannot
tell
Cannot
tell
Yes Competition of interest: none
Kapma32 Prospective Concurrent cohort of patients
undergoing open repair not
eligible for EVAR because of
short neck, aorto-iliac
aneurysm, or no access
Cannot
tell
Yes Yes Not declared
Mehta31 Prospective Concurrent cohort of patients
with symptomatic AAA
undergoing EVAR
Cannot
tell
Cannot
tell
Yes Competition of interest: none
Leon36 Retrospective Concurrent cohort of patients
undergoing open repair.
Method of selection of
patients for open or EVAR not
described
Cannot
tell
Yes No Competition of interest: none
Brandt30 Retrospective Historical cohort of patients with
ruptured aneurysms treated
with open repair at the same
center before the introduction
of REVAR
No Yes Yes None of the authors have
identified a conflict of
interest
Larzon34 Retrospective Concurrent cohort of patients
undergoing open repair (1)
not eligible for EVAR because
of technical limitations or
circulatory shock; or (2) not
treated with EVAR because of
lack of trained staff
Cannot
tell
Yes Cannot
tell
The authors have no
commercial proprietary or
financial interest in any
products or companies
described in this article.
Alsac35 Prospective Concurrent cohort of patients
undergoing open repair (1)
not eligible for EVAR because
of unsuitable anatomy or
circulatory shock; or (2) not
treated with EVAR because of
lack of equipment
Cannot
tell
Yes Yes Not declared
Hinchliffe25 Prospective No control group Cannot
tell
Cannot
tell
No Grant from Vascutek,
Renfrewshire, Scotland;
Generous help from Cook
Inc. and Cook Europe;
Support from the
Nottingham vascular
surgery research fund; SW
Yusuf was funded by the
university hospital.
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Reference
Direction of
inquiry Control group
Outcome
assessors
blinded
Outcomes
specified
a priori
Algorithm
used Funding
Veith26 Prospective No control group Cannot
tell
Cannot
tell
Yes Not declared
Moore38 Prospective Control groups consisted of
patients with RAAA
undergoing REVAR prior to
implementation of an
algorithm, and both
concurrent and historical
RAAA treated with open
repair.
Cannot
tell
Yes Yes Competition of interest: none
Lagana27 Prospective No control group Cannot
tell
Cannot
tell
Cannot
Tell
Not declared
Peppelenbosch33 Prospective Concurrent cohort of patients
with ruptured aneurysms
undergoing open repair who
were not eligible for EVAR
Cannot
tell
Yes Yes MedtronicREVAR, Endovascular repair of ruptured aortic aneurysm; EVAR, endovascular aneurysm repair; RAAA, ruptured abdominal aortic aneurysms.
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Volume 47, Number 1 Mastracci et al 221.e9Table VI, online only. Details of algorithms for assessing eligibility for endovascular repair of ruptured aortic
aneurysms
Reference
Algorithm
described
Consecutive
patients
screened
Description of
EVAR expertise
Protocol for blood
pressure management
Imaging
required
Anatomic
eligibility
parameter
Routine
occlusion
balloon
Scharrer-Pamler 21 Yes No 12 cases by surgery
and radiology,
14 cases by
surgery alone
Hypotensive
haemostasis was
initiated to stabilize
blood pressure, and
fluid resuscitation
was minimized as
long as the SBP did
not fall below 50
mm HG
CT or US Not described No
Resch28 Yes Cannot tell 70% of elective
infrarenal
aneurysms at
their center are
repaired using
EVAR
Not described Not described Not described No
Castelli37 Yes Yes A senior vascular
surgeon and
interventional
radiologist, and
other people as
necessary
Fluid administration to
keep SBP near the
range of 60 to 70
mm Hg, usually 80
mm Hg. Only those
patients who had
uncompensated
shock received
sympathetic amines.
CTA or US Not described No
Lee29 Yes After protocol
initiated
”the hospital also
committed the
requisite human
resources to
support an
emergency staff,
which included
an experienced
endovascular
scrub technician
and an
equipment
specialist who
could assemble
rapidly to
prepare for an
EVAR”
No fluid resuscitation
unless SBP  80
mm Hg or
decreased mentation
CT if stable
(SBP  80
mmHg)
Anatomic
exclusion
criteria:
absence of a
suitable
proximal
neck (26
mm in
diameter,
10 mm in
length); or
bilateral
small (7
mm
diameter)
EIA or
severe
occlusive
disease
No
Hechelhammer22 Yes Cannot tell 2 vascular
surgeons, 2
interventional
radiologists
performing
EVAR together,
70 elective
EVAR per year
A hypotensive
haemostatic
approach with
restricted fluid
resuscitation and
limited
administration of
catecholamines was
applied.
CT if stable Minimal
proximal
neck length
of 15 mm
No
Peppelenbosch23 Yes Cannot tell Not described Intravenous fluid
infusion rate was
Yes Not described Nominimized
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Reference
Algorithm
described
Consecutive
patients
screened
Description of
EVAR expertise
Protocol for blood
pressure management
Imaging
required
Anatomic
eligibility
parameter
Routine
occlusion
balloon
Gerassimidis24 Yes Yes On-call surgeon Intravenous fluid and
blood resuscitation
were minimized
before aneurysm
exclusion to keep
the SBP between 80
and 100 mm Hg.
Intravenous
nitroglycerin in
hemodynamically
stable patients with a
contained rupture
was not used.
Yes General
guidelines:
an
infrarenal
neck length
of 10 mm
or more, a
neck
diameter of
32 mm or
less, neck
angulation
of 60
degrees or
less and a
common
iliac
diameter of
22 mm or
less; no
bilateral
common
iliac
aneurysms
or long iliac
occlusions.
No
Kapma32 Yes Yes REVAR was
considered only
when an
endovascular
team was
present.
Not described US and then
CT if stable
Anatomic
suitability:
proximal
neck length
 15 mm
with less
than 60
degrees
angulation,
and access
vessels large
enough to
accommodate
the
introducer
systems
No
Mehta31 Yes Yes ”the procedures
were well
rehearsed with
the
anesthesiologists,
the operating
room staff and
the radiology
technicians that
were
knowledgeable
of the sequence
of steps
involved.”
”We routinely used the
technique of
hypotensive
hemostasis in all
patients with
[RAAA] by limiting
resuscitation and
maintaining a
detectable blood
pressure to limit the
potential for
ongoing
hemorrhage.”
CT only if
stable
”We accepted
an aortic
neck length
 5 mm,
and
inability to
gain access
from the
femoral
arteries was
never a
limiting
factor.”
No
36Leon No Not described Not described Not described Not described Not described Not described
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Reference
Algorithm
described
Consecutive
patients
screened
Description of
EVAR expertise
Protocol for blood
pressure management
Imaging
required
Anatomic
eligibility
parameter
Routine
occlusion
balloon
Brandt30 Yes Yes after
REVAR
introduced
Elective experience
gained before
REVAR offered.
Not described US and then
CT if stable
Absolute
criteria:
neck length
 10 - 15
mm,
diameter 
30 mm.
Relative
criteria:
thrombus
 40% of
circumference,
calcification
 80% of
circumference,
neck
angulation

90degrees;
additional
iliac criteria
No
Larzon34 Cannot
tell
No “a vascular surgeon
trained in
endovascular
procedures”
Not described CT if stable Not described No
Alsac35 Yes Yes All operations were
performed in the
operating room
by a surgeon and
an interventional
radiologist.
The patients were
managed with
permissive
hypotension (110
mm Hg)
CT if stable Proximal neck
length 
15 mm;
neck
diameter 
32 mm;
neck
angulation
 90
degrees
No
Hinchliffe25 No Yes EVAR was only
considered when
there was an
available team of
operators trained
in the
radiological,
surgical and
technical aspects
of the procedure
”. . . all patients had
restricted fluid
administration . . .”
No Proximal neck
diameter 
32 mm;
neck length
 15 mm;
neck
angulation
 60
degrees,
common
iliac artery
 22 mm
No
Veith26 Yes Yes Not described ”. . . we coined the
term hypotensive
hemostasis. By that
we mean
aggressively
restricting all fluid in
ruptured aneurysms
patients as long as
they remain
conscious and able
to talk and move.
We accept a
reduction in arterial
SBP to the 50 to 70
mm Hg range”
CT only if
stable, then
angio in the
OR
Not described Guidewire,
but no
balloon
Moore38 Yes Yes Only offered when
an endovascular
specialist was on
Consciousness and
SBP  80 mmHg
CT if stable Not described Pendingcall
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Reference
Algorithm
described
Consecutive
patients
screened
Description of
EVAR expertise
Protocol for blood
pressure management
Imaging
required
Anatomic
eligibility
parameter
Routine
occlusion
balloon
Lagana27 Cannot
tell
Cannot tell ”. . . team of
interventional
radiologists,
vascular surgeons
and anesthetists
. . .”
”. . . preoperative fluid
resuscitation was
administered to
maintain the systolic
pressure near 80 mm
Hg . . .”
CT if stable Not described No
Peppelenbosch33 Yes Yes ”Vascular surgeons
and
interventional
radiologists with
considerable
experience in the
diagnosis and
open and
endovascular
treatment of
[RAAA] were
included as
investigators in
this study.”
”. . . on arrival in the
emergency
department,
intravenous fluid
infusion was
minimized, and if
necessary, medication
to lower blood
pressure was
administered.”
CT if stable “. . . anatomic
criteria for
treatment
by open
surgery
included an
infrarenal
aortic neck
of  10
mm or a
diameter of
[] 32
mm, or
both. In
addition, an
angulation
of the
infrarenal
neck of 
85° was
considered
an
exclusion
criterion for
EVAR, as
were
bilateral
iliac artery
occlusions
or stenosis
not
amenable
to balloon
angioplasty.”
NoSBP, Systolic blood pressure; CT, computed tomography;US, ultrasound; EVAR, endovascular aneurysm repair; CTA, computed tomographic angiography;
EIA, external iliac artery; REVAR, endovascular repair of ruptured aneurysms; RAAA, ruptured abdominal aortic aneurysm; OR, operating room.
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category of ineligibility criteria
Reason for ineligibility
Reference Hemo-dynamics Imaging
Graft
availability
Team or
surgeon
availability
Neck
angulation Neck length
Other
anatomy
Total
number of
ruptured
aneurysms
Scharrer-
Pamler21
Not described Not described Not described Not described Not described Not described Not described 67
Resch28 2 0 11 7 0 1 2 36
Castelli37 0 0 3 0 0 8 10 46
Lee29 0 0 0 2 0 1 1 36
Hechelhammer22 Not described Not described Not described Not described Not described Not described Not described 89
Peppelenbosch23 Not described Not described Not described Not described Not described Not described Not described 101
Gerassimidis24 2 died on
arrival
0 0 0 Not described Not described 15 40
Kapma32 8 0 0 4 Not described Not described 28 59
Mehta31 Not described Not described Not described Not described Not described Not described Not described 85
Leon36 Not described Not described Not described Not described Not described Not described Not described 2118
Brandt30 0 0 0 2 0 5 6 24
Larzon34 5 0 0 17 0 2 2 50
Alsac35 8 0 5 0 0 0 9 37
Hinchliffe25 Not described Not described Not described Not described Not described Not described Not described 20
Veith26 Not described Not described Not described Not described Not described Not described Not described Not
described
Moore38 Pending Pending Pending Pending Pending Pending Pending 115
Lagana27 Not described Not described Not described Not described Not described Not described Not described 23
Peppelenbosch33 7 0 0 2 2 34 4 100
Total 32 0 19* 34* 2 51 77 3046
*In studies reporting reasons for ineligibility, 12% of patients were ineligible because of administrative (lack of availability of graft or of endovascular team)
rather than clinical reasons.Table VIII, online only. Adverse events† reported in studies of endovascular repair of ruptured aneurysms
Reference
Number of
patients
undergoing
REVAR
Renal failure
requiring
dialysis
(temporary or
permanent) Paraplegia
Abdominal
compartment
syndrome
Myocardial
infarction
Bowel
ischemia
Respiratory
failure
Scharrer-Pamler 200321 24 0 0 0 * 0 *
Resch 200328 21 1 * * * * *
Castelli 200537 25 2 * 1 * 1 *
Lee 200429 13 * * * * * *
Hechelhammer 200522 37 4 0 3 * * *
Peppelenbosch 200523 35 * 4 * 3 1 3
Gerassimidis 200524 23 1 * * 3 * 4
Kapma 200532 25 * * 1 * 1 *
Leon 200536 55 * * * * * *
Brandt 200530 11 * * * * * *
Larzon 200534 15 * 2 1 1 * *
Alsac 200535 17 * * 1 0 1 1
Hinchliffe 200125 20 * * * 1 * 1
Veith 200326 30 * * 2 * * *
Moore 200638 19 * * * * * *
Lagana 200627 23 2 * 0 * * *
Peppelenbosch 200633 49 1 2 0 5 2 2
Mehta 200631 42 2 * 7 2 2 2
REVAR, Endovascular repair of ruptured aneurysm.
*Not reported.
†Adverse events are defined as reported by individual authors.
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Reference
Number of patients
undergoing REVAR
Duration of follow- up, mo
(range, if reported)
Deaths on long-term
follow-up
Scharrer-Pamler 200321 24 Mean 30 (2.8 - 8) 6
Resch 200328 21  
Castelli 200537 25 Mean 7 (4 - 24) 
Lee 200429 13 Mean 6.8 (0.1 - 16.3) 2
Hechelhammer 200522 37 Mean 24 (0.25- 63) 7
Peppelenbosch 200523 35  
Gerassimidis 200524 23 Median 14 (3 - 55) 11
Kapma 200532 25  
Leon 200536 55  
Brandt 200530 11  
Larzon 200534 15  
Alsac 200535 17 Mean 6 (1.1 - 26.3) 6
Hinchliffe 200125 20 Mean 12 (1 - 72) 12
Veith 200326 30  
Moore 200638 19  
Lagana 200627 23 Mean 15.2 (1 - 32) 0
Peppelenbosch 200633 49 Mean 3 20
Mehta 200631 42 Mean 17 REVAR, Endovascular repair of ruptured aneurysm.
*Not reported.
